Nicolas Lefèbvre
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
- Parasitology top 10%
Papers in
-
- COVID-19 Clinical Research Studies 5
- Antimicrobial Resistance in Staphylococcus 4
- Tuberculosis Research and Epidemiology 4
- Epidemiology 17
- Infective Endocarditis Diagnosis and Management 8
- Pneumonia and Respiratory Infections 3
- Co-authors
- Yves Hansmann (35 shared papers)Dennis Falzon (2 shared papers)Yvon Ruch (18 shared papers)X. Argémi (8 shared papers)François Danion (12 shared papers)Thibaut Fabacher (7 shared papers)Daniel Christmann (6 shared papers)Charlotte Kaeuffer (9 shared papers)
- Journals
- Clinical Microbiology and Infection (3 papers)International Journal of Infectious Diseases (2 papers)BMC Infectious Diseases (2 papers)Emerging infectious diseases (2 papers)Open Forum Infectious Diseases (2 papers)
- Partner nations
- FranceSwitzerlandSenegal
In The Last Decade
Nicolas Lefèbvre
57 papers receiving 780 citations
Peers
Comparison fields: 5 of 99
- Infectious Diseases 371
- Parasitology 52
- Clinical Biochemistry 50
- Neurology 73
- Epidemiology 151
Countries citing papers authored by Nicolas Lefèbvre
This map shows the geographic impact of Nicolas Lefèbvre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Lefèbvre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Lefèbvre more than expected).
Fields of papers citing papers by Nicolas Lefèbvre
This network shows the impact of papers produced by Nicolas Lefèbvre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Lefèbvre. The network helps show where Nicolas Lefèbvre may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicolas Lefèbvre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 84 | |
| 2 | 2008 | 82 | |
| 3 | 2015 | 56 | |
| 4 | 2020 | 50 | |
| 5 | 2020 | 41 | |
| 6 | 2012 | 38 | |
| 7 | 2017 | 30 | |
| 8 | 2016 | 27 | |
| 9 | 2017 | 27 | |
| 10 | 2019 | 26 | |
| 11 | 2019 | 25 | |
| 12 | 2010 | 21 | |
| 13 | 2015 | 19 | |
| 14 | 2007 | 16 | |
| 15 | 2013 | 15 | |
| 16 | 1981 | 15 | |
| 17 | 2022 | 12 | |
| 18 | 2012 | 12 | |
| 19 | 2005 | 12 | |
| 20 | 2020 | 12 |
About Nicolas Lefèbvre
Nicolas Lefèbvre is a scholar working on Infectious Diseases, Epidemiology, Surgery, Pathology and Forensic Medicine and Neurology, having authored 63 papers that have together received 808 indexed citations. Recurring topics across this work include Infective Endocarditis Diagnosis and Management (8 papers), Infectious Diseases and Tuberculosis (6 papers), COVID-19 Clinical Research Studies (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Diagnosis and treatment of tuberculosis (4 papers), Tuberculosis Research and Epidemiology (4 papers), Long-Term Effects of COVID-19 (4 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Infectious Diseases (371 citations), Parasitology (52 citations), Clinical Biochemistry (50 citations), Neurology (73 citations) and Epidemiology (151 citations). Nicolas Lefèbvre has collaborated with scholars based in France, Switzerland and Senegal. Frequent co-authors include Yves Hansmann, Dennis Falzon, Yvon Ruch, X. Argémi, François Danion, Thibaut Fabacher, Daniel Christmann, Charlotte Kaeuffer, Frédéric Schramm and Valentin Greigert. Their work appears in journals such as Clinical Microbiology and Infection, International Journal of Infectious Diseases, BMC Infectious Diseases, Emerging infectious diseases and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.